Search details
1.
TFEB Overexpression, Not mTOR Inhibition, Ameliorates RagCS75Y Cardiomyopathy.
Int J Mol Sci
; 22(11)2021 May 23.
Article
in English
| MEDLINE | ID: mdl-34071043
2.
Exon- and contraction-dependent functions of titin in sarcomere assembly.
Development
; 143(24): 4713-4722, 2016 12 15.
Article
in English
| MEDLINE | ID: mdl-27836965
3.
Activation of γ2-AMPK Suppresses Ribosome Biogenesis and Protects Against Myocardial Ischemia/Reperfusion Injury.
Circ Res
; 121(10): 1182-1191, 2017 Oct 27.
Article
in English
| MEDLINE | ID: mdl-28835357
4.
Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion.
J Mol Cell Cardiol
; 100: 64-71, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-27693463
5.
De novo RRAGC mutation activates mTORC1 signaling in syndromic fetal dilated cardiomyopathy.
Hum Genet
; 135(8): 909-917, 2016 08.
Article
in English
| MEDLINE | ID: mdl-27234373
6.
Mutation in the γ2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage.
Circ Res
; 114(6): 966-75, 2014 Mar 14.
Article
in English
| MEDLINE | ID: mdl-24503893
7.
Functional characterization and identification of a therapeutic for a novel SCN5A-F1760C variant causing type 3 long QT syndrome refractory to all guideline-directed therapies.
Heart Rhythm
; 20(5): 709-717, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36731785
8.
SGK1 inhibition attenuates the action potential duration in reengineered heart cell models of drug-induced QT prolongation.
Heart Rhythm
; 20(4): 589-595, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36610526
9.
SGK1 inhibition attenuated the action potential duration in patient- and genotype-specific re-engineered heart cells with congenital long QT syndrome.
Heart Rhythm O2
; 4(4): 268-274, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-37124559
10.
AMPK isoform expression in the normal and failing hearts.
J Mol Cell Cardiol
; 52(5): 1066-73, 2012 May.
Article
in English
| MEDLINE | ID: mdl-22314372
11.
Targeting AMPK for cardiac protection: opportunities and challenges.
J Mol Cell Cardiol
; 51(4): 548-53, 2011 Oct.
Article
in English
| MEDLINE | ID: mdl-21147121
12.
Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats.
J Mol Cell Cardiol
; 51(2): 144-55, 2011 Aug.
Article
in English
| MEDLINE | ID: mdl-21549710
13.
Development of a Patient-Specific p.D85N-Potassium Voltage-Gated Channel Subfamily E Member 1-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for Drug-Induced Long QT Syndrome.
Circ Genom Precis Med
; 14(3): e003234, 2021 06.
Article
in English
| MEDLINE | ID: mdl-34003017
14.
Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity.
Sci Adv
; 6(5): eaay2939, 2020 01.
Article
in English
| MEDLINE | ID: mdl-32064346
15.
Role of resistin in cardiac contractility and hypertrophy.
J Mol Cell Cardiol
; 45(2): 270-80, 2008 Aug.
Article
in English
| MEDLINE | ID: mdl-18597775
16.
Transcript variant dictates Prkag2 cardiomyopathy?
J Mol Cell Cardiol
; 53(3): 317-9, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22789965
17.
Defective Branched-Chain Amino Acid Catabolism Disrupts Glucose Metabolism and Sensitizes the Heart to Ischemia-Reperfusion Injury.
Cell Metab
; 25(2): 374-385, 2017 02 07.
Article
in English
| MEDLINE | ID: mdl-28178567
18.
Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a.
PLoS One
; 4(7): e6474, 2009 Jul 31.
Article
in English
| MEDLINE | ID: mdl-19649297
Results
1 -
18
de 18
1
Next >
>>